Skip to main content

Table 1 Respondent Characteristics

From: Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial

VARIABLEPARTICIPANTS (n = 26)
Age
 20–293
 30–3911
 40–496
 50–593
 60–693
Gender
 Women19
 Men6
 Transgender1
Educationa
 Some college1
 Technical/associate degree2
 Bachelor2
 Master8
 PhD5
 MD10
Study role
 Site PI4
 Study clinician7
 Study coordinator8
 Research assistant5
 Outreach worker1
 QA monitor1
Years at clinic
 1–38
 4–65
 7–92
 10–123
 13–165
 17–190
 20+3
Years experience with HIV or SUD
 1–34
 4–66
 7–92
 10–122
 13–166
 17–192
 20+4
Years experience with MOUD
 1–315
 4–64
 7–91
 10–123
 13–162
 17–190
 20+1
  1. aNumbers will equal more than 26 as some participants reported more than 1 degree
  2. MOUD Medications for opioid use disorder treatment (e.g. naltrexone, buprenorphine, and methadone)